Private Advisory Group LLC Eli Lilly & CO Transaction History

Private Advisory Group LLC

$820 Million
Q3 2024

A detailed history of Private Advisory Group LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Private Advisory Group LLC holds 20,587 shares of LLY stock, worth $16.4 Million. This represents 2.22% of its overall portfolio holdings.

Number of Shares

20,587

Previous 20,354 1.14%

Holding current value

$16.4 Million

Previous $18.4 Million 1.03%

% of portfolio

2.22%

Previous 2.46%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 09, 2024	BUY	$772.14 - $960.02 $179,908 - $223,684	233 Added 1.14%	20,587 $18.2 Million
Q2 2024 Jul 23, 2024	BUY	$724.87 - $909.04 $799,531 - $1 Million	1,103 Added 5.73%	20,354 $18.4 Million
Q1 2024 May 14, 2024	BUY	$592.2 - $792.28 $922,055 - $1.23 Million	1,557 Added 8.8%	19,251 $15 Million
Q4 2023 Feb 13, 2024	BUY	$525.19 - $619.13 $475,822 - $560,931	906 Added 5.4%	17,694 $10.3 Million
Q3 2023 Nov 13, 2023	BUY	$434.7 - $599.3 $429,483 - $592,108	988 Added 6.25%	16,788 $9.02 Million
Q2 2023 Jan 12, 2024	SELL	$350.74 - $468.98 $346,531 - $463,352	-988 Reduced 5.89%	15,800 $7.41 Million
Q2 2023 Aug 11, 2023	BUY	$350.74 - $468.98 $5.07 Million - $6.79 Million	14,469 Added 1087.08%	15,800 $7.41 Million
Q1 2023 May 12, 2023	SELL	$310.63 - $364.82 $1.66 Million - $1.95 Million	-5,337 Reduced 80.04%	1,331 $457,000
Q4 2022 Feb 13, 2023	BUY	$321.55 - $374.67 $275,568 - $321,092	857 Added 14.75%	6,668 $2.44 Million
Q3 2022 Nov 10, 2022	BUY	$296.48 - $337.87 $107,918 - $122,984	364 Added 6.68%	5,811 $1.88 Million
Q2 2022 Aug 12, 2022	BUY	$278.73 - $327.27 $1.16 Million - $1.37 Million	4,173 Added 327.55%	5,447 $1.77 Million
Q1 2022 May 13, 2022	BUY	$234.69 - $291.66 $298,995 - $371,574	1,274 New	1,274 $365,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Advisory Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Advisory Group LLC with notifications on news.

Account

Private Advisory Group LLC Eli Lilly & CO Transaction History